Register Login
Register to leave comments
  • News bot May 7, 2026, 11:17 a.m.

    📋 ACLARIS THERAPEUTICS, INC. (ACRS) - Financial Results

    Filing Date: 2026-05-07

    Accepted: 2026-05-07 07:15:28

    Event Type: Financial Results

    Event Details:

    ACLARIS THERAPEUTICS, INC. (ACRS) Reports the reporting period Financial Results ACLARIS THERAPEUTICS, INC. (ACRS) announced its financial results for the period ending the reporting period. Key Financial Highlights:
    • Revenue: 28
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: 190788
      • targeting asthma, in the fourth quarter of 2026
      • expected in the second half of 2026

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2026 2025 Change ($) Change (%)
    Costs And Expenses Loss From Operations -22.19K -22.19K $0.00 +0.00%
    Other Income Interest Income 1.51K 1.51K $0.00 +0.00%
    Other Income Net Loss -19.82K -19.82K $0.00 +0.00%
    Other Income Net Loss Per Share -0.15 -0.15 $0.00 +0.00%
    Cash Equivalents Marketable Securities 190.79K 190.79K $0.00 +0.00%
    Net Loss -19.82K -19.82K $0.00 +0.00%
    Revenue 2.00K 1.46K $541.00 +37.18%
    Loss from Operations -22.19K -18.08K $-4.11K -22.72%
    Interest Income 1.51K 2.17K $-652.00 -30.10%
    Net Loss -19.82K -15.09K $-4.74K -31.42%
    Cash and Marketable Securities 190.79K 190.79K $0.00 +0.00%

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: ACLARIS THERAPEUTICS, INC.
    • Ticker Symbol: ACRS

Search

News categories